Multiple Manufacturers

CRYSVITA

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Multiple Manufacturers

Crysvita HCPCS:

J0584

HCPCS Code Descriptor:

Injection, burosumab-twza 1 mg

Category:

J Code

Crysvita NDCs:

69794-0304-01, 42747-0304-01, 69794-0102-01, 42747-0203-01, 69794-0203-01, 42747-0102-01

Primary Type:

Unclassified

Generic/Specialty Status:

Multi-Source

Package Type:

Vial

Route of Administration:

Subcutaneous

Crysvita CPT Codes:

Some of the most common CPT administration codes for 'buy and bill' drugs can be found at the following link:

Potential NDC Listing Errors:

We have not identified any potential errors with the NDCs mapped to this HCPCS code.

About Crysvita:

CRYSVITA is a medication manufactured by multiple manufacturers and aligned to the J Code: J0584. CRYSVITA is administered via the subcutaneous route of administration.

ACCESS PRICING AND MORE BY REGISTERING

J0584 Added Date:

January 1, 2019

J0584 Effective Date:

January 1, 2019

J0584 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Crysvita billing and coding information.
Crysvita patient assistance information can be found through UltraCare at the URL: https://www.ultracaresupport.com/patient-services/
CRYSVITA prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for CRYSVITA. Please check back in a few weeks.